Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee

(1) Background: osteoarthritis (OA) of the knee is a degenerative disease accompanied by pain, reduced mobility and subsequent decrease in quality of life. Many studies on OA of the knee have reported that using an intercellular acting-derivate like platelet-rich plasma (PRP) results in a limited ef...

Full description

Bibliographic Details
Main Authors: Hieronymus P. Stevens, Joeri van Boxtel, Robbert van Dijck, Joris A. van Dongen
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/10/14/4691
_version_ 1797563100493250560
author Hieronymus P. Stevens
Joeri van Boxtel
Robbert van Dijck
Joris A. van Dongen
author_facet Hieronymus P. Stevens
Joeri van Boxtel
Robbert van Dijck
Joris A. van Dongen
author_sort Hieronymus P. Stevens
collection DOAJ
description (1) Background: osteoarthritis (OA) of the knee is a degenerative disease accompanied by pain, reduced mobility and subsequent decrease in quality of life. Many studies on OA of the knee have reported that using an intercellular acting-derivate like platelet-rich plasma (PRP) results in a limited effect or none at all. Authors hypothesized that adding tissue-Stromal Vascular Fraction (tSVF) to PRP (Platelet Rich Stroma (PRS)) would reduce pain and improve functionality in osteoarthritis of the knee. (2) Methods: a consecutive case series of fifteen patients (aged 43–75 years) suffering from OA of the knee (Kellgren–Lawrence stage two to three) were treated with a single injection of autologous PRS. tSVF was mechanically isolated by means of the fractionation of adipose tissue (FAT) procedure. Clinical evaluation was done using a visual analogue score (VAS) score, an adapted Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) and Lysholm score at fixed time points: pre-injection as well as three, six and twelve months post injection. (3) Results: VAS and WOMAC scores improved significantly after twelve months (<i>p</i> < 0.01 and <i>p</i> < 0.05). Lysholm instability scores were also improved at twelve months (<i>p</i> > 0.05) in comparison to pre-injection measurements. No complications were seen in any of the patients. One patient was excluded due to a total knee arthroplasty. (4) Conclusions: a single injection with PRS for OA of the knee seems to lead to an improvement of function and simultaneous reduction of pain and joint stiffness for a period of twelve months. Further controlled trials are required to determine the optimal treatment regimen and evaluate long-term results.
first_indexed 2024-03-10T18:37:47Z
format Article
id doaj.art-b51fcd21d5ed49bab31af9ddf5c9d447
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-10T18:37:47Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-b51fcd21d5ed49bab31af9ddf5c9d4472023-11-20T06:08:34ZengMDPI AGApplied Sciences2076-34172020-07-011014469110.3390/app10144691Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the KneeHieronymus P. Stevens0Joeri van Boxtel1Robbert van Dijck2Joris A. van Dongen3PRSkliniek.nl, Rotterdam-Vlaardingen, Churchillsingel 472, 3127 XB Vlaardingen, The NetherlandsDepartment of Plastic Surgery, University of Groningen and University Medical Center Groningen, 9713 GZ Groningen, The NetherlandsBergman Clinics, 4817 BL Breda, The NetherlandsDepartment of Plastic Surgery, University of Groningen and University Medical Center Groningen, 9713 GZ Groningen, The Netherlands(1) Background: osteoarthritis (OA) of the knee is a degenerative disease accompanied by pain, reduced mobility and subsequent decrease in quality of life. Many studies on OA of the knee have reported that using an intercellular acting-derivate like platelet-rich plasma (PRP) results in a limited effect or none at all. Authors hypothesized that adding tissue-Stromal Vascular Fraction (tSVF) to PRP (Platelet Rich Stroma (PRS)) would reduce pain and improve functionality in osteoarthritis of the knee. (2) Methods: a consecutive case series of fifteen patients (aged 43–75 years) suffering from OA of the knee (Kellgren–Lawrence stage two to three) were treated with a single injection of autologous PRS. tSVF was mechanically isolated by means of the fractionation of adipose tissue (FAT) procedure. Clinical evaluation was done using a visual analogue score (VAS) score, an adapted Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) and Lysholm score at fixed time points: pre-injection as well as three, six and twelve months post injection. (3) Results: VAS and WOMAC scores improved significantly after twelve months (<i>p</i> < 0.01 and <i>p</i> < 0.05). Lysholm instability scores were also improved at twelve months (<i>p</i> > 0.05) in comparison to pre-injection measurements. No complications were seen in any of the patients. One patient was excluded due to a total knee arthroplasty. (4) Conclusions: a single injection with PRS for OA of the knee seems to lead to an improvement of function and simultaneous reduction of pain and joint stiffness for a period of twelve months. Further controlled trials are required to determine the optimal treatment regimen and evaluate long-term results.https://www.mdpi.com/2076-3417/10/14/4691SVFPRPknee osteoarthritisregenerative
spellingShingle Hieronymus P. Stevens
Joeri van Boxtel
Robbert van Dijck
Joris A. van Dongen
Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
Applied Sciences
SVF
PRP
knee osteoarthritis
regenerative
title Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
title_full Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
title_fullStr Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
title_full_unstemmed Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
title_short Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
title_sort platelet rich stroma the combination of prp and tsvf and its potential effect on osteoarthritis of the knee
topic SVF
PRP
knee osteoarthritis
regenerative
url https://www.mdpi.com/2076-3417/10/14/4691
work_keys_str_mv AT hieronymuspstevens plateletrichstromathecombinationofprpandtsvfanditspotentialeffectonosteoarthritisoftheknee
AT joerivanboxtel plateletrichstromathecombinationofprpandtsvfanditspotentialeffectonosteoarthritisoftheknee
AT robbertvandijck plateletrichstromathecombinationofprpandtsvfanditspotentialeffectonosteoarthritisoftheknee
AT jorisavandongen plateletrichstromathecombinationofprpandtsvfanditspotentialeffectonosteoarthritisoftheknee